1. Home
  2. IMMX vs VLRS Comparison

IMMX vs VLRS Comparison

Compare IMMX & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

HOLD

Current Price

$7.96

Market Cap

784.8M

Sector

Health Care

ML Signal

HOLD

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

SELL

Current Price

$5.89

Market Cap

923.4M

ML Signal

SELL

Company Overview

Basic Information
Metric
IMMX
VLRS
Founded
2014
2005
Country
United States
Mexico
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
784.8M
923.4M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
IMMX
VLRS
Price
$7.96
$5.89
Analyst Decision
Strong Buy
Buy
Analyst Count
7
14
Target Price
★ $24.30
$9.04
AVG Volume (30 Days)
★ 1.6M
356.9K
Earning Date
11-06-2026
10-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.35
Revenue Next Year
N/A
$7.74
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.71
$5.79
52 Week High
$15.10
$10.80

Technical Indicators

Market Signals
Indicator
IMMX
VLRS
Relative Strength Index (RSI) 27.55 29.34
Support Level $7.96 N/A
Resistance Level $10.61 $7.15
Average True Range (ATR) 0.59 0.21
MACD -0.17 -0.04
Stochastic Oscillator 1.73 6.25

Price Performance

Historical Comparison
IMMX
VLRS

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: